Oxidative stress in the neonate.

Area of Science:

• Neonatal physiology
• Oxidative stress research
• Perinatal medicine

Background:

• Neonates face oxidative stress at birth, with preterm infants being more vulnerable.
• Antioxidant defenses like alpha-tocopherol and Coenzyme Q10 (Co Q10) are crucial for neonates.
• Oxygen therapy, while necessary, may impact oxidative balance in preterm infants.

Purpose of the Study:

• To assess the oxidative state of term and preterm neonates at birth and early life.
• To investigate the influence of oxygen exposure on oxidative markers in preterm neonates.
• To evaluate levels of hydroperoxides, alpha-tocopherol, and Co Q10 in erythrocyte membranes.

Main Methods:

• Comparative study of 20 neonates (10 term, 10 preterm).
• Analysis of erythrocyte membrane hydroperoxides, alpha-tocopherol, and Co Q10.
• Sample collection at various time points from birth up to 7 days.

Main Results:

• Elevated hydroperoxide levels (oxidative stress markers) were observed in both groups at birth, higher in preterm infants.
• Preterm neonates had significantly lower alpha-tocopherol levels at birth and failed to show the increase seen in term infants.
• Coenzyme Q10 levels decreased, potentially impacting tocopherol regeneration; oxygen therapy maintained low antioxidant levels in preterm infants.

Conclusions:

• Neonates, particularly preterm infants, are born with heightened oxidative stress and diminished antioxidant capacity.
• Gestational age significantly influences the balance between oxidative stress and antioxidant defenses.
• Oxygen therapy in preterm neonates may not improve, and could potentially hinder, the restoration of antioxidant balance.